Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia

Respiratory Medicine

Volumn 140, Issue , 2018, Pages 115-121

  Arnold, Forest W ^a,f   Lopardo, Gustavo ^b   Wiemken, Timothy L ^a   Kelley, Robert ^a   Peyrani, Paula ^a,f   Mattingly, William A ^a   Feldman, Charles ^c,bw   Gnoni, Martin ^d,az   Maurici, Rosemeri ^e   Ramirez, Julio A ^a   Ramirez, Julio ^f   Ayesu, Kwabena ^g   File, Thomas ^h   Burdette, Steven ⁱ   Blatt, Stephen ^d   Restrepo, Marcos ^j   Bordon, Jose ^k   Gross, Peter ^l   Musher, Daniel ^m   Marrie, Thomas ⁿ   Weiss, Karl ^o   Roig, Jorge ^p   Lode, Harmut ^q   Welte, Tobias ^r   Aliberti, Stephano ^s   Blasi, Francesco ^s   Cosentini, Roberto ^t   Legnani, Delfino ^u   Franzetti, Fabio ^u   Montano, Nicola ^u   Cervi, Giulia ^v   Rossi, Paolo ^w   Voza, Antonio ^x   Ostrowsky, Belinda ^s   Pesci, Alberto ^s   Nava, Stefano ^y   Viale, Pierluigi ^y   Galavatti, Vanni ^z   Patricia, Aruj ^aa   Dimas, Carlos ^ab   Piro, Roberto ^ac   Viscoli, Claudio ^ad   Torres, Antoni ^ae   Valenti, Vincenzo ^af   Ojales, Daniel Portela ^ag   Bodi, Maria ^ah   Porras, Jose ^ah   Rello, Jordi ^ah   Menendez, Rosario ^ai   Stolz, Daiana ^aj   Schuetz, Philipp ^ak   Haubitz, Sebastian ^ak   Chalmers, James ^al   Fardon, Tom ^am   Benchetrit, Guillermo ^an   Rodriguez, Eduardo ^ao   Corral, Jorge ^ap   Gonzalez, Jose ^aq   de Vedia, Lautaro ^ar   Luna, Carlos ^as   Martinez, Jorge ^at   Marzoratti, Lucia ^au   Rodriguez, Maria ^av   Videla, Alejandro ^aw   Saavedra, Federico ^ax   Lopez, Horacio ^ay   Victorio, Carlos ^ba   Riera, Fernando ^bb   Jimenez, Patricio ^bc   Fernandez, Patricia ^bd   Parada, Maria ^be   Fuenzalida, Alejandro Díaz ^bf   Riquelme, Raul ^bg   Barros, Manuel ^bh   Luna, Juan Manuel ^bi   Toala, Ivan ^bj   Oze de Morvil, Guillermo Arbo ^bk   Fernandez, Ricardo ^bl   Aiello, Gonzalo ^bm   Alvarez, Pablo ^bm   Soca, Ana ^bn   Arteta, Federico ^bo   Delgado, Jose ^bp   Levy, Gur ^bq   Rivero, Ludwig ^br   Rodriguez, Benito ^bs   Mirabal, Mario Perez ^bt   Mateo, Marilyn ^bu   Mendoza, Myrna ^bv   more..

^a University of Louisville School of Medicine   (United States)

^b Hospital Bernardo Houssay in northern Buenos Aires   (Argentina)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d GOOD SAMARITAN HOSPITAL   (United States)

^e FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g ORLANDO REGIONAL MEDICAL CENTER   (United States)

^h NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

ⁱ MIAMI VALLEY HOSPITAL   (United States)

^j UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^k Providence Hospital Washington DC   (United States)

^l HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^m MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^o MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^p HOSPITAL NOSTRA SENYORA DE MERITXELL   (Andorra)

^q City Hospital Emil von Behring/Lungenklinik Heckeshorn   (Germany)

^r HANNOVER MEDICAL SCHOOL   (Germany)

^s SAN GERARDO HOSPITAL   (Italy)

^t Policlinico   (Italy)

^u UNIVERSITY OF MILAN   (Italy)

^v UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^w SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^x HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^y UNIVERSITY OF BOLOGNA   (Italy)

^z CARLO POMA HOSPITAL   (Italy)

^aa SANT ANNA HOSPITAL   (Italy)

^ab SAN CARLO BORROMEO HOSPITAL   (Italy)

^ac S MARIA NUOVA HOSPITAL   (Italy)

^ad St Martin General Hospital   (Italy)

^ae Instituto de Neumonologia Y Cirugia Toracica   (Spain)

^af HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^ag HOSPITAL XERAL CÍES   (Spain)

^ah HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^ai HOSPITAL UNIVERSITARIO LA FE   (Spain)

^aj UNIVERSITY HOSPITAL BASEL   (Switzerland)

^ak CANTONAL HOSPITAL AARAU   (Switzerland)

^al ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^am NINEWELLS HOSPITAL   (United Kingdom)

^an INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^ao HOSPITAL ESPAÑOL   (Argentina)

^ap Hospital Espanol de La Plata ^*  (Argentina)

^aq Tornu Hospital   (Argentina)

^ar HOSPITAL F J MUÑIZ   (Argentina)

^as HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^at Instituto Medico Platense   (Argentina)

^au Sanatorio 9 de Julio   (Argentina)

^av Hospital Prof Rodolfo Rossi La Plata   (Argentina)

^aw UNIVERSIDAD AUSTRAL   (Argentina)

^ax Sanatorio Otamendi y Miroli   (Argentina)

^ay Centro de Infectologia   (Argentina)

^az Sanatorio Central Emprendimientos Medicos Hospitalarios Sociedad Anonima   (Argentina)

^ba Clinica Uruguay   (Argentina)

^bb HOSPITAL PRIVADO   (Argentina)

^bc HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^bd INSTITUTO NACIONAL DEL TÓRAX   (Chile)

^be CLÍNICA LAS CONDES   (Chile)

^bf PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^bg Hospital Regional de Puerto Montt   (Chile)

^bh HOSPITAL CARLOS VAN BUREN   (Chile)

^bi Roosevelt Hospital   (Guatemala)

^bj HMDrAAM CSS)   (Panama)

^bk Centre for Gynaecological Endoscopy Cendogyn   (Paraguay)

^bl National Weather Service   (Puerto Rico)

^bm HOSPITAL MACIEL   (Uruguay)

^bn Hospital Pasteur Montevideo   (Uruguay)

^bo Asociacion Cardiovascular Centroccidental Venezuela   (Venezuela)

^bp HOSPITAL CENTRAL DR URQUINAONA   (Venezuela)

^bq HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^br University Central Hospital Antonio Maria Pineda   (Venezuela)

^bs Ministerio del Poder Popular para el Trabajo y Seguridad Social Venezuela   (Venezuela)

^bt Hospital Universitario de Los Andes   (Venezuela)

^bu UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

^bv UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^bw UNIVERSITY OF THE WITWATERSRAND   (South Africa)

more..

Author keywords

Antimicrobial treatment; Bacteremia; Community acquired pneumonia; Mortality

Indexed keywords

AMIKACIN; ATOVAQUONE; BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; COLISTIMETHATE; COTRIMOXAZOLE; GENTAMICIN; MACROLIDE; METRONIDAZOLE; OSELTAMIVIR; PENTAMIDINE; PRIMAQUINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER INFECTION; ADULT; ALL CAUSE MORTALITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CLINICAL OUTCOME; COMBINATION DRUG THERAPY; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI INFECTION; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HAEMOPHILUS INFECTION; HOSPITAL MORTALITY; HOSPITAL PATIENT; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MORAXELLACEAE INFECTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEUS INFECTION; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; SECONDARY ANALYSIS; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; AGED; BACTERIAL PNEUMONIA; CLINICAL TRIAL; COMMUNITY ACQUIRED INFECTION; FACTUAL DATABASE; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MACROLIDES; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 85048390451     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2018.05.020     Document Type: Article

References (27)

1. FastStats Deaths and Mortality. Centers for Disease Control and Prevention Web Site, October 7, 2016 http://www.cdc.gov/nchs/fastats/deaths.htm. (Accessed 14 October 2016)
2. Demartini, G., Esposti, D., Marthyn, P., Lapidari, A., Fraschini, F., Scaglione, F., Effect of multiple doses of clarithromycin and amoxicillin on IL-6, IFNgamma and IL-10 plasma levels in patients with community acquired pneumonia. J. Chemother. 16:1 (2004), 82–85, 10.1179/joc.2004.16.1.82.
3. Lagrou, K., Peetermans, W.E., Jorissen, M., Verhaegen, J., Damme, J.V., Van Eldere, J., Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro. J. Antimicrob. Chemother. 46:5 (2000), 717–723, 10.1093/jac/46.5.717.
4. Koch, C.C., Esteban, D.J., Chin, A.C., et al. Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae. J. Antimicrob. Chemother. 46:1 (2000), 19–26, 10.1093/jac/46.1.19.
5. Arnold, F.W., LaJoie, A.S., Brock, G.N., et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: community-Acquired Pneumonia Organization International cohort study results. JAMA Intern. Med. 169:16 (2009), 1515–1524, 10.1001/archinternmed.2009.265.
6. Niederman, M.S., Mandell, L.A., Anzueto, A., et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 163 (2001), 1730–1754, 10.1164/ajrccm.163.7.at1010.
7. Zou, G., A modified Poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 159:7 (2004), 702–706.
8. Sun, G., Shook, T., Kay, G., Inappropriate use of bivariable analysis to screen factors for use in multivariable analysis. J. Clin. Epidemiol. 49 (1996), 907–916.
9. Restrepo, M.I., Mortensen, E.M., Waterer, G.W., Wunderink, R.G., Coalson, J.J., Anzueto, A., Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia. Eur. Respir. J. 33:1 (2009), 153–159, 10.1183/09031936.00054108.
10. Arnold, F.W., Bordon, J., Fernandez-Botran, R., et al. Macrolide use and neutrophil function/cytokine levels in hospitalized patients with community-acquired pneumonia: a pilot study. Lung 194:1 (2016), 155–162, 10.1007/s00408-015-9822-7.
11. Fernandez-Botran, R., Uriarte, S.M., Arnold, F.W., et al. Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia. Inflammation 37:4 (2014), 1158–1166, 10.1007/s10753-014-9840-2.
12. Metersky, M.L., Ma, A., Houck, P.M., Bratzler, D.W., Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones. Chest 131:2 (2007), 466–473, 10.1378/chest.06-1426.
13. Nie, W., Li, B., Xiu, Q., beta-Lactam/macrolide dual therapy versus beta-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. J. Antimicrob. Chemother. 69:6 (2014), 1441–1446, 10.1093/jac/dku033.
14. Dwyer, R., Ortqvist, A., Aufwerber, E., et al. Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 25:8 (2006), 518–521, 10.1007/s10096-006-0183-2.
15. Martinez, J.A., Horcajada, J.P., Almela, M., et al. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 36:4 (2003), 389–395, 10.1086/367541.
16. Naucler, P., Darenberg, J., Morfeldt, E., Ortqvist, A., Henriques Normark, B., Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia. Thorax 68:6 (2013), 571–579, 10.1136/thoraxjnl-2012-203106.
17. Waterer, G.W., Somes, G.W., Wunderink, R.G., Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch. Intern. Med. 161:15 (2001), 1837–1842, 10.1001/archinte.161.15.1837.
18. Postma, D.F., van Werkhoven, C.H., van Elden, L.J., et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N. Engl. J. Med. 372:14 (2015), 1312–1323, 10.1056/NEJMoa1406330.
19. Brown, R.B., Iannini, P., Gross, P., Kunkel, M., Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database. Chest 123:5 (2003), 1503–1511, 10.1378/chest.123.5.1503.
20. Mortensen, E.M., Restrepo, M.I., Anzueto, A., Pugh, J., The impact of empiric antimicrobial therapy with a beta-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia. Crit. Care, 10(1), 2006, R8, 10.1186/cc3934.
21. Rodrigo, C., McKeever, T.M., Woodhead, M., Lim, W.S., Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia. Thorax 68:5 (2013), 493–495, 10.1136/thoraxjnl-2012-202296.
22. Asadi, L., Sligl, W.I., Eurich, D.T., et al. Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis. Clin. Infect. Dis. 55:3 (2012), 371–380, 10.1093/cid/cis414.
23. Sligl, W.I., Asadi, L., Eurich, D.T., Tjosvold, L., Marrie, T.J., Majumdar, S.R., Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis. Crit. Care Med. 42:2 (2014), 420–432, 10.1097/CCM.0b013e3182a66b9b.
24. Skalsky, K., Yahav, D., Lador, A., Eliakim-Raz, N., Leibovici, L., Paul, M., Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials. Clin. Microbiol. Infect. 19:4 (2013), 370–378, 10.1111/j.1469-0691.2012.03838.x.
25. Raz-Pasteur, A., Shasha, D., Paul, M., Fluoroquinolones or macrolides alone versus combined with beta-lactams for adults with community-acquired pneumonia: systematic review and meta-analysis. Int. J. Antimicrob. Agents 469:3 (2015), 242–248, 10.1016/j.ijantimicag.2015.04.010.
26. Shefet, D., Robenshtok, E., Paul, M., Leibovici, L., Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch. Intern. Med. 165:17 (2005), 1992–2000, 10.1001/archinte.165.17.1992.
27. Parkman, H.P., Hasler, W.L., Fisher, R.S., American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127:5 (2004), 1592–1622, 10.1053/j.gastro.2004.09.055.